<code id='F6AAB522B6'></code><style id='F6AAB522B6'></style>
    • <acronym id='F6AAB522B6'></acronym>
      <center id='F6AAB522B6'><center id='F6AAB522B6'><tfoot id='F6AAB522B6'></tfoot></center><abbr id='F6AAB522B6'><dir id='F6AAB522B6'><tfoot id='F6AAB522B6'></tfoot><noframes id='F6AAB522B6'>

    • <optgroup id='F6AAB522B6'><strike id='F6AAB522B6'><sup id='F6AAB522B6'></sup></strike><code id='F6AAB522B6'></code></optgroup>
        1. <b id='F6AAB522B6'><label id='F6AAB522B6'><select id='F6AAB522B6'><dt id='F6AAB522B6'><span id='F6AAB522B6'></span></dt></select></label></b><u id='F6AAB522B6'></u>
          <i id='F6AAB522B6'><strike id='F6AAB522B6'><tt id='F6AAB522B6'><pre id='F6AAB522B6'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:hotspot    Page View:478
          David Sabatini
          Wikimedia Commons

          Former MIT and Whitehead Institute star biologist David Sabatini, who lost his positions after he was accused of violating sexual harassment policies in 2021, is resuming his science career, taking a post at a Czech research institute in Prague.

          Sabatini, of Cambridge, confirmed in a phone call from Prague that he has accepted a position as a “senior group leader” at the Institute of Organic Chemistry and Biochemistry, known as IOCB Prague. Sabatini said he will be recruiting staff and running a laboratory in the Czech Republic capital to investigate scientific questions in the areas of cell growth and metabolism, similar to his past research in Cambridge.

          advertisement

          “I’m very grateful to be given the opportunity to do science again,” said Sabatini, who began working at the institute last month.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Wegovy’s successful heart trial raises vital question about weight loss
          Wegovy’s successful heart trial raises vital question about weight loss

          BloombergAlandmarkstudythatfoundtheblockbusterobesitydrugWegovyreducesthechanceofheartproblemsaddsur

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

          SammyKimballforSTATAredrugpricesprotectedbytheConstitution?WillMedicareembraceAlzheimer’sdiseasetrea